Blood biomarkers for multiple sclerosis: neurofilament light chain and beyond.
出版信息
EBioMedicine. 2024 Jun;104:105214. doi: 10.1016/j.ebiom.2024.105214.
Abstract
摘要
相似文献
1
Blood biomarkers for multiple sclerosis: neurofilament light chain and beyond.用于多发性硬化症的血液生物标志物：神经丝轻链及其他。
EBioMedicine. 2024 Jun;104:105214. doi: 10.1016/j.ebiom.2024.105214.
2
Neurofilament light chain levels in MS: At the doorstep of clinical application.多发性硬化症中神经丝轻链水平：迈向临床应用的门槛。
Neurol Neuroimmunol Neuroinflamm. 2019 Aug 16;6(5). doi: 10.1212/NXI.0000000000000601. Print 2019 Sep.
3
Serum NFL levels should be used to monitor multiple sclerosis evolution - No.血清神经丝轻链水平应用于监测多发性硬化症的进展——否。
Mult Scler. 2020 Jan;26(1):19-21. doi: 10.1177/1352458519872891. Epub 2019 Oct 18.
4
Serum NfL levels should be used to monitor multiple sclerosis evolution - Yes.血清神经丝轻链水平应用于监测多发性硬化症的进展——是。
Mult Scler. 2020 Jan;26(1):17-19. doi: 10.1177/1352458519872921. Epub 2019 Oct 18.
5
Serum NFL levels should be used to monitor multiple sclerosis evolution - Commentary.血清神经丝轻链水平应用于监测多发性硬化症的进展——评论。
Mult Scler. 2020 Jan;26(1):21-22. doi: 10.1177/1352458519880471. Epub 2019 Oct 18.
6
Mounting evidence for a multiple sclerosis prodrome.多发性硬化症前驱期的证据越来越多。
Nat Rev Neurol. 2019 Dec;15(12):689-690. doi: 10.1038/s41582-019-0283-0.
7
[Evaluation of serum neurofilament light chains levels for diagnosis, treatment monitoring and prognosis in multiple sclerosis].[血清神经丝轻链水平在多发性硬化症诊断、治疗监测及预后评估中的应用]
Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(10. Vyp. 2):7-13. doi: 10.17116/jnevro20191191027.
8
Comparison of Simoa and Ella to assess serum neurofilament-light chain in multiple sclerosis.比较 Simoa 和 Ella 检测多发性硬化症患者血清神经丝轻链。
Ann Clin Transl Neurol. 2021 May;8(5):1141-1150. doi: 10.1002/acn3.51355. Epub 2021 Apr 8.
9
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders.神经丝轻链血清水平反映了与MOG抗体相关疾病的疾病严重程度。
J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1293-1296. doi: 10.1136/jnnp-2018-320287. Epub 2019 Apr 5.
10
Serum Neurofilament Light and Multiple Sclerosis Progression Independent of Acute Inflammation.血清神经丝轻链与多发性硬化症的进展不依赖于急性炎症。
JAMA Netw Open. 2022 Feb 1;5(2):e2147588. doi: 10.1001/jamanetworkopen.2021.47588.
引用本文的文献
1
Brain-derived blood biomarkers in multiple sclerosis-current trends and beyond.多发性硬化症中脑源性血液生物标志物——当前趋势及未来展望
Front Immunol. 2025 Jun 16;16:1569503. doi: 10.3389/fimmu.2025.1569503. eCollection 2025.
Zotero 插件